Stealthy catheter developer Route 92 Medical, which is developing a catheter to treat stroke, last week said it raised nearly $13 million in an equity round.
Founded in 2015, San Mateo, Calif.-based Route 92 won 510(k) clearance from the FDA a year ago for a percutaneous catheter. The company holds U.S. patents for treating acute ischemic stroke, a rapid aspiration thrombectomy system and intra-cerebral implant delivery.
According to regulatory filings, Route 92 first drummed up $5.9 million in May 2016. Just less than a year later the company doubled that raise, adding another $4.7 million in August 2018. Including the most-recent May 25 filing, Route 92 Medical has raised $29.5 million in equity rounds.
Deep in stealth mode, the company’s website lists only its address and a contact form. Its founder and CEO is Tony Chou, who is also a general partner at the Vertical Group, according to his LinkedIn profile.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!